KMID : 0982820030020010006
|
|
Journal of Lung Cancer 2003 Volume.2 No. 1 p.6 ~ p.9
|
|
Adjuvant Chemotherapy for Completely Resected Non-Small Cell Lung Cancer
|
|
Kim Sang-We
|
|
Abstract
|
|
|
Lung cancer is the number one cause of cancer-related deaths in Korea. Non- small cell lung cancers account for about 80% of these cases. Because the long term survival of patients after a complete resection is poor, postoperative adjuvant chemotherapy seems to be a very promising concept. However, studies on postoperative chemotherapy, to date, have been disappointing. Recently, the International Adjuvant Lung Cancer Trial (IALT) reported an absolute 5% statistically significant 5-year survival benefit (p£¼0.03). Further studies, which could select patients favored with adjuvant chemotherapy, are necessary.
|
|
KEYWORD
|
|
Non-small cell lung cancer, Adjuvant chemotherapy
|
|
FullTexts / Linksout information
|
|
|
|
Listed journal information
|
|
|